Melis M - Search Results

1

Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.

de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Krenning EP, de Jong M. de Visser M, et al. Among authors: melis m. J Nucl Med. 2007 Jan;48(1):88-93. J Nucl Med. 2007. PMID: 17204703 Free article.

2

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.

Schroeder RP, Müller C, Reneman S, Melis ML, Breeman WA, de Blois E, Bangma CH, Krenning EP, van Weerden WM, de Jong M. Schroeder RP, et al. Among authors: melis ml. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1386-96. doi: 10.1007/s00259-010-1388-2. Epub 2010 Feb 25. Eur J Nucl Med Mol Imaging. 2010. PMID: 20182713 Free PMC article.

3

Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy.

Melis M, Forrer F, Capello A, Bijster M, Bernard BF, Reubi JC, Krenning EP, De Jong M. Melis M, et al. Q J Nucl Med Mol Imaging. 2007 Dec;51(4):324-33. Q J Nucl Med Mol Imaging. 2007. PMID: 17923824 Free article.

4

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

de Jong M, Barone R, Krenning E, Bernard B, Melis M, Visser T, Gekle M, Willnow TE, Walrand S, Jamar F, Pauwels S. de Jong M, et al. Among authors: melis m. J Nucl Med. 2005 Oct;46(10):1696-700. J Nucl Med. 2005. PMID: 16204720 Free article.

5

Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.

Melis M, Krenning EP, Bernard BF, de Visser M, Rolleman E, de Jong M. Melis M, et al. Nucl Med Biol. 2007 Aug;34(6):633-41. doi: 10.1016/j.nucmedbio.2007.05.002. Nucl Med Biol. 2007. PMID: 17707803

6

Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.

Schroeder RP, de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Breeman WA, Krenning EP, de Jong M. Schroeder RP, et al. Among authors: melis m. Int J Cancer. 2010 Jun 15;126(12):2826-34. doi: 10.1002/ijc.25000. Int J Cancer. 2010. PMID: 19876914 Free article.

7

Nephrotoxicity in mice after repeated imaging using 111In-labeled peptides.

Melis M, Vegt E, Konijnenberg MW, de Visser M, Bijster M, Vermeij M, Krenning EP, Boerman OC, de Jong M. Melis M, et al. J Nucl Med. 2010 Jun;51(6):973-7. doi: 10.2967/jnumed.109.074310. Epub 2010 May 19. J Nucl Med. 2010. PMID: 20484435 Free article.

8

Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy.

Melis M, de Swart J, de Visser M, Berndsen SC, Koelewijn S, Valkema R, Boerman OC, Krenning EP, de Jong M. Melis M, et al. J Nucl Med. 2010 Dec;51(12):1962-8. doi: 10.2967/jnumed.110.080143. Epub 2010 Nov 15. J Nucl Med. 2010. PMID: 21078795 Free article.

9

Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration.

Melis M, Valkema R, Krenning EP, de Jong M. Melis M, et al. J Nucl Med. 2012 May;53(5):749-53. doi: 10.2967/jnumed.111.098665. Epub 2012 Apr 10. J Nucl Med. 2012. PMID: 22496587 Free article.

10

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.

Dalm SU, Martens JW, Sieuwerts AM, van Deurzen CH, Koelewijn SJ, de Blois E, Maina T, Nock BA, Brunel L, Fehrentz JA, Martinez J, de Jong M, Melis M. Dalm SU, et al. Among authors: melis m. J Nucl Med. 2015 May;56(5):752-7. doi: 10.2967/jnumed.114.153023. Epub 2015 Mar 19. J Nucl Med. 2015. PMID: 25791989 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,098 results

Search Page

Filters